Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

CME

Gastro-esophageal Reflux Disease (GERD): The Spectrum of Esophagitis, Barrett's, Dysplasia and Cancer

GERD is a very common entity but the frequency of Barrett's in mild GERD or in patients with few or no symptoms is unknown.
CME credit is no longer available for this conference.

Course Authors

Gary M. Gray, M.D.

Dr. Gray reports no commercial conflict of interest.

Estimated course time: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Analyze the history of a patient with GERD and establish a systematic approach to the diagnosis and therapy

  • Discuss the pathophysiology of intestinal metaplasia (Barrett's epithelium) in the lower esophagus

  • Recognize the factors that increase the risk of developing Barrett's epithelium

  • Determine when a patient with Barrett's should be referred to a gastroenterologist or surgeon.

 

TERMS AND CONDITIONS

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity

Courses You Might Like

GI Manifestations of Covid-19

The coronavirus disease-2019 (COVID-19) is more than a respiratory condition. We look at its GI manifestations.
Authors: Max Schmulson, M.D., R.F.F.
Estimated Time: 1 Hour
More

Treatment of Hepatocellular Carcinoma

Hepatocellular carcinoma is the third leading cause of cancer-related death worldwide. We review the treatment options and recommendations for patients with HCC.
Authors: Brian C. Davis, M.D., and Amit G. Singal, M.D., M.S.
Estimated Time: 1 Hour
More

Pancreatic Adenocarcinoma

Pancreatic cancer continues to far outpace its incidence rate with respect to mortality.
Authors: Parvin Peddi, M.D., and Andrea Wang-Gillam, M.D.
Estimated Time: 1 Hour
More

The Indigenous Gastrointestinal Microbiota in Health and Disease

The microbiota can play key roles both in maintenance of health as well as the pathogenesis of disease within the gastrointestinal tract.
Authors: John Y. Kao, M.D., Nirmal Kaur, M.D., and Vincent B. Young M.D., Ph.D.
Estimated Time: 1 Hour
More

Liver Fibrosis: New Mechanisms, New Treatments, and Why They Matter

Liver fibrosis, like pathological fibrosis in other organs, has been termed "wound healing gone bad."
Authors: Rebecca G. Wells, M.D.
Estimated Time: 1 Hour
More

Chronic Pancreatitis: Diagnosis and Management

The most common etiology of chronic pancreatitis is alcohol abuse.
Authors: Stephen Pandol, M.D., and Hartley Cohen, M.D.
Estimated Time: 1 Hour
More